Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114400 · ClinicalTrials.gov registry record · Phase 2
BVAIT: B-Vitamin Atherosclerosis Intervention Trial
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 2
- Development phase
- 506
- Enrollment target
NCT00114400 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 506 participants.
The verdict
NCT00114400, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 506 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).
Interventions
- DRUG folic acid
- DRUG vitamin B12
- DRUG vitamin B6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2000-11 |
| Est. Completion | 2007-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00114400
The ClinicalTrials.gov registry entry for NCT00114400 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 506 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which folic acid is the first listed.
NCT00114400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00114400 about?
NCT00114400 is a clinical study titled "BVAIT: B-Vitamin Atherosclerosis Intervention Trial". The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).
What is the current status of trial NCT00114400?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 506 participants. The study started on 2000-11. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00114400?
The interventions under investigation include: folic acid (DRUG), vitamin B12 (DRUG), vitamin B6 (DRUG).
Who is sponsoring clinical trial NCT00114400?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.